Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience.
Lichtenstein L, Koslowsky B, Ben Ya'acov A, Avni-Biron I, Ovadia B, Ben-Bassat O, Naftali T, Kopylov U, Haberman Y, Eran HB, Eliakim R, Lahat-Zok A, Hirsch A, Zittan E, Maharshak N, Waterman M, Israeli E, Goren I, Ollech JE, Yanai H, Ungar B, Avidan B, Ben Hur D, Melamud B, Segol O, Shalem Z, Dotan I, Odes SH, Ben-Horin S, Snir Y, Milgrom Y, Broide E, Goldin E, Delgado S, Ron Y, Cohen NA, Maoz E, Zborovsky M, Odeh S, Abu Freha N, Shachar E, Chowers Y, Engel T, Reiss-Mintz H, Segal A, Zinger A, Bar-Gil Shitrit A. Lichtenstein L, et al. Among authors: naftali t. Vaccines (Basel). 2022 Feb 28;10(3):376. doi: 10.3390/vaccines10030376. Vaccines (Basel). 2022. PMID: 35335008 Free PMC article.
Cannabis for inflammatory bowel disease.
Naftali T, Mechulam R, Lev LB, Konikoff FM. Naftali T, et al. Dig Dis. 2014;32(4):468-74. doi: 10.1159/000358155. Epub 2014 Jun 23. Dig Dis. 2014. PMID: 24969296 Review.
Revealing the Puzzle of Nonadherence in IBD-Assembling the Pieces.
Eindor-Abarbanel A, Naftali T, Ruhimovich N, Bar-Gil Shitrit A, Sklerovsky-Benjaminov F, Konikoff F, Matalon S, Shirin H, Milgrom Y, Broide E. Eindor-Abarbanel A, et al. Among authors: naftali t. Inflamm Bowel Dis. 2018 May 18;24(6):1352-1360. doi: 10.1093/ibd/izy013. Inflamm Bowel Dis. 2018. PMID: 29718228
Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC Study.
Ungar B, Engel T, Yablecovitch D, Lahat A, Lang A, Avidan B, Har-Noy O, Carter D, Levhar N, Selinger L, Neuman S, Natour OH, Yavzori M, Fudim E, Picard O, Kopylov U, Chowers Y, Naftali T, Broide E, Shachar E, Eliakim R, Ben-Horin S. Ungar B, et al. Among authors: naftali t. Am J Gastroenterol. 2018 Jun;113(6):890-898. doi: 10.1038/s41395-018-0073-0. Epub 2018 Jun 5. Am J Gastroenterol. 2018. PMID: 29867175
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience.
Kopylov U, Avni-Biron I, Ron Y, Koslowsky B, Waterman M, Daher S, Ungar B, Schwartz D, Zittan E, Openhaim M, Yanai H, Maharshak N, Bar Gil Shitrit A, Naftali T, Eliakim R, Chowers Y, Ben-Horin S, Dotan I. Kopylov U, et al. Among authors: naftali t. Dig Liver Dis. 2019 Jan;51(1):68-74. doi: 10.1016/j.dld.2018.07.040. Epub 2018 Aug 10. Dig Liver Dis. 2019. PMID: 30172649 Clinical Trial.
The Relationship between Gender, Severity of Disease, Treatment Type, and Employment Outcome in Patients with Inflammatory Bowel Disease in Israel.
Naftali T, Eindor-Abarbanel A, Ruhimovich N, Bar-Gil Shitrit A, Sklerovsky-Benjaminov F, Konikoff F, Matalon S, Shirin H, Milgrom Y, Ziv-Baran T, Broide E. Naftali T, et al. Can J Gastroenterol Hepatol. 2018 Sep 9;2018:5090849. doi: 10.1155/2018/5090849. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30271766 Free PMC article.
84 results